Dietary fats and oils: Technologies for improving cardiovascular health

Current Atherosclerosis Reports

Volumn 6, Issue 6, 2004, Pages 468-476

  Flickinger, Brent D ^a   Huth, Peter J ^b  

^a James R Randall Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOHYDRATE; CONJUGATED LINOLEIC ACID; COTTON SEED OIL; DOCOSAHEXAENOIC ACID; EDIBLE OIL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDIUM CHAIN TRIACYLGLYCEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PHYTOSTEROL; POLYUNSATURATED FATTY ACID; RAPESEED OIL; SATURATED FATTY ACID; SOYBEAN OIL; STANOL ESTER; STEARIC ACID; SUNFLOWER OIL; UNINDEXED DRUG;

ANTIARRHYTHMIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG MECHANISM; ENERGY CONSUMPTION; FAT INTAKE; FOOD COMPOSITION; FOOD INDUSTRY; FOOD PROCESSING; GOVERNMENT REGULATION; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; NUTRITIONAL REQUIREMENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 9744254410     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-004-0088-4     Document Type: Review

References (82)

1. Ridker PM, Brown NJ, Vaughn DE, et al.: Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004, 109 (Suppl IV 6-19.
2. Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. In Institute of Medicine of the National Academies. Washington, DC: The National Academies Press; 2002.
3. Dreon DM, Fernstrom HA, Miller B, Krauss RM: Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J 1994, 8:121-126.
4. Krauss RM, Dreon DM: Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr 1995, 62:478S-487S.
5. Dreon DM, Fernstrom HA, Miller B, Krauss RM: Apolipoprotein E isoform phenotype and LDL subclass response to a reduced fat diet. Thromb Vasc Biol 1995, 15:105-111.
6. Blake GJ, 0tvos JD, Difai N, Ridker PM: Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 2002, 106:1930-1937.
7. Kuller L, Arnold A, Tracy R, et al.: Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health study. Arterioscler Thromb Vasc Biol 2002, 22:1175-1180.
8. Rosenson RS, Otvos JD, Freedman DS: Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 2002, 90:89-94.
9. Mensink RP, Zock PL, Kester A, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1455.
10. Hu FB, Stampler MJ, Manson J, et al.: Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997, 337:1491-1499.
11. Sacks FM: Dietary fats and coronary heart disease. Overview. J Cardiovasc Risk 1994, 1:3-8.
12. Sundram K, Hayes KC, Sru OH: A balance between dietary 18:2 and 16:0 may be required to improve the serum LDL/HDL cholesterol ration in normocholesterolemic men. J Nutr Biochem 1995, 6 179-187.
13. Clandinin MT, Cook SL, Konard SD, French MA: The effect of palmitic acid on lipoprotein cholesterol levels. Int J Food Sci Nutr 2000, 51:S61-S71.
14. Yu S, Derr J, Etherton TD, Kris-Etherton PM: Plasma cholesterolpredictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic. Am J Clin Nutr 1995, 61:1129-1139.
15. Renaud S, Morazain P, Godsey F, et al.: Nutrients, platelet function and composition in nine groups of French and British farmers. Atherosclerosis 1986, 60:37-48.
16. Hoak J: Fatty acids in animals: thrombosis and hemostasis Am J Clin Nutr 1997, 65(Suppl):1683S-1686S.
17. Dietary fatty acids, hemostasis, and cardiovascular disease risk. J Am Diet Assoc 2004, 104:410-419.
18. Turpeinen AM, Pajari AM, Freese R, et al.: Replacement of dietary saturated by unsaturated fatty acids: effects of platelet protein kinase C activity, urinary content of 2,3-dinor-TXB2 and in vitro platelet aggregation in healthy man. Thromb Haemost 1998, 80:649-655.
19. Turpeinen AM, Wubert J, Aro A, et al.: Similar effects of diets rich in stearic acid or trans-fatty acids on platelet function and endothelial prostacyclin production in humans. Arterioscler Thromb Vasc Biol 1998, 18:316-322.
20. Kelly FD, Sinclair AJ, Mann NJ, et al.: A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males. Eur J Clin Nutr 2001, 55:88-96.
21. Kelly FD, Sinclair AJ, Mann NJ, et al.: Short-term diets enriched in stearic acid or palmitic acids do not alter plasma lipids, platelet aggregation or platelet activation status. Eur J Clin Nutr 2002, 56:490-499.
22. Tholstrup T, Marckmann P, Jesperson J, Sandstrom B: Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am J Clin Nutr 1994, 59 371-377.
23. Hunter KA, Crosbie LC, Weir A, et al.: A residential study comparing the effects of diets rich in stearic acid, oleic acid, and linoleic acid on fasting lipids, hemostatic variables and platelets in young healthy men. J Nutr Biochem 2000, 11:408-416.
24. Baer DJ, Judd JT, Clevidence BA, Tracy RP: Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004, 79 969-973.
25. Tholstrup T, Marckmann P, Hermansen J, et al.: Effect of modified dairy fat on fasting and postprandial haemostatic variables in healthy young men. Br J Nutr 1999, 82 105-113.
26. Marckmann P, Sandstrom B, Jespersen J: Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: Observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994, 59 935-939.
27. Marckmann P, Sandstrom B, Jespersen J: Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 1993, 13:505-511.
28. Marckmann P, Sandstrom B, Jespersen J: Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb 1992, 12:201-205.
29. Niskanen L, Schwab US, Sarkkinen ES, et al.: Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance. Metabolism 1997, 46:666-672.
30. Erickson DR, Erickson MD: Hydrogenation and base stock formulation procedures. In Practical Handbook of Soybean Processing and Utilization. Edited by Erickson DR. Champaign, IL: AOCS Press; 1995:218-238.
31. Allison DB, Egan SK, Barraj LM, et al.: Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 1999, 99:166-174.
32. Food, Fats and Oils, edn 7. Washington, DC: Institute of Shortening and Edible Oils; 1994:25.
33. Oil Crops Situation and Outlook Yearbook. In Market and Trade Economics Division, Economic Research Service, US Department of Agriculture, October 2003, OCS-2003.
34. Erickson MD: Interesterification. In Practical Handbook of Soybean Processing and Utilization. Edited by Erickson DR. Champaign, IL: AOCS Press; 1995:218-238.
35. List GR, Emken EA, Kwolek WF, et al.: "Zero trans" margarines: preparation, structure, and properties of interesterified soybean oil - soy trisaturate blends. J Am Oil Chem Soc 1977, 54:408-413.
36. List GR, Pelloso T, Orthoefer F, et al.: Preparation and properties of zero trans soybean oil margarines. J Am Oil Chem Soc 1995, 72:383-384.
37. List GR, Mounts TL, Orthoefer F, Neff WE: Margarine and shortening oils by interesterification of liquid and trisaturated triglycerides. J Am Oil Chem Soc 1995, 72:379-382.
38. Food labeling: trans fatty acids in nutrition labeling. Food and Drug Administration. 2003, Fed Reg 68:41433-41506.
39. List GR, Steidley KR, Neff WE: Commercial spreads formulation, structure and properties. Inform 2000, 11 980-986.
40. Ratnayake WM, Pelletier G, Hollywood R, et al.: Trans fatty acids in Canadian margarines: recent trends. J Am Oil Chem Soc 1998, 75:1587-1594.
41. Petrauskaite VW, DeGreyt A, Kellens M, Huyghaebaert A: Physical and chemical properties of trans free fats produced by chemical interesterification of vegetable oil blends. J Am Oil Chem Soc 1998, 75:489-493.
42. Ozay G, Yildiz M, Mahidin M, et al.: Formulation of trans free fatty acid margarines. In Proceedings of World Conference on Oilseed and Edible Oil Processing. Edited by Koseoglu S, Rhee K, Wilste RF. Champaign, IL: AOCS Press; 1998:143-146.
43. Yusoff M, Kifli H, Noorlida H, Rozig MP: Formulation of transfree margarines. In Proceedings of World Conference on Oilseed and Edible Oil Processing. Edited by Koseoglu S, Rhee K, Wilste RF. Champaign, IL: AOCS Press; 1998:156-158.
44. Hunter JE: Studies on effects of dietary fatty acids as related to their position on triglycerides. Lipids 2001, 36 655-668.
45. Judd JT, Baer DJ, Clevidence BA, et al.: Dietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men. Lipids 2002, 37:123-131.
46. Aro A, Jauhiainen M, Partanen R, et al.: Steraric acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am J Clin Nutr 1997, 65:1419-1426.
47. Bubeck DM, Fehr WR, Hammond EG: Inheritance of palmitic and stearic acid mutants of soybean. Crop Sci 1989, 29 652-656.
48. Hammond EG, Fehr WR: Registration of A6 germplasm line of soybean. Crop Sci 1983, 23:192-193.
49. Liu K: Modifying soybean oil through plant breeding and genetic engineering. Proceedings of the World Conference on Oilseed Processing and Utilization. Edited by Wilson RF Champaign, IL: AOCS Press; 2001:84-89.
50. Liu K, Corliss G, Orthoefer FT, Brown EA: Properties and applications of specially bred soybean oil. Paper presented at the 88th American Oil Chemists' Society Annual Meeting and Expo. Seattle, WA, May 11-14, 1997.
51. Osorio J, Fernandez-Martinez J, Mancha M, Garces R: Mutant sunflowers with high concentration of saturated fatty acids in the oil Crop Sci 1995, 35:739-742.
52. Facclotti MT, Bertain PB, Yuan L: Improved stearate phenotype in transgenic canola expressing a modified acyl-acyl carrier protein thioesterase. Nat Biotech 1999, 17:593-597.
53. Liu Q, Surinder S, Green A: High-oleic and high stearic cottonseed oils: nutritionally improved cooking oils developed using gene silencing. J Am Coll Nutr 2002; 21:205S-211S.
54. List GR, Mounts TI, Orthoefer F, Neff WE: Effect of interesterification on the structure and physical properties of high-stearic acid soybean oils. J Am Oil Chem Soc 1997, 74 327-329.
55. List GR, Mounts TL, Orthoefer F, Neff WE: Potential margarine oils from genetically modified soybeans. J Am Oil Chem Soc 1996, 73:729-732.
56. List GR: Trans acids in specialty lipids. Proceedings of the 3rd International World Conference on Nutraceutricals and Functional Foods. San Diego, CA, November 16-18, 2002. Edited by Koserln SF and Shahidi. Worldnutra 2002, 15:1-6.
57. Binkoski AE, Kris-Etherton P, Nicolosi RJ: Lipid-lowering effects of a mid-oleic sunflower oil in moderately hypercholesterolemic men and women. FASEB J 2003, 17:A7930.
58. Truswell AS, Choudhury N: Monounsaturated oils do not all have the same effect on plasma cholesterol. Eur J Clin Nutr 1998, 52:312-315.
59. Wardlaw GM, Snook JT: Effect of diets high in butter, corn oil, or high-oleic acid sunflower oil on serum lipids and apolipoproteins in men. Am J Clin Nutr 1990, 51:815-821.
60. Rudel LL, Haines JL, Sawyer JK: Effects on plasma lipoproteins on monounsaturated, saturated, and polyunsaturated fatty acids in the diet of African green monkeys. J Lipid Res 1990, 31:1873-1882.
61. Rudel LL, Parks JS, Sawyer JK: Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery disease. Arterioscler Thromb Vasc Biol 1995, 15:2101-2110.
62. James MJ, Ursin VM, Cleland LG: Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr 2003, 77:1140-1145.
63. Franklin ST, Martin KR, Baer RJ, et al.: Dietary marine algae (Schizochytrium sp.) increases concentrations of conjugated linoleic, docosahexaenoic and transvaccenic acids in milks of dairy cows J Nutr 1999, 129:2048-2052.
64. Offer NW, Marsden M, Dixon J, et al.: Effect of dietary fat supplements on levels of n-3 poly-unsaturated fatty acids, trans acids and conjugated linoleic acid in bovine milk. Animal Sci 1999, 69:613-625.
65. Kitessa SM, Gulati SK, Simos GC, et al.: Supplementation of grazing dairy cows with rumen-protected tuna oil enriches milk fat with n-3 fatty acids without affecting milk production or sensory characteristics. Br J Nutr 2004, 91:271-277.
66. Jarnum S, Jensen H: Medium chain triglycerides (MCT) in the treatment of protein-losing enteropathy and malabsorption syndromes Scand J Gastroenterol 1966, 1:306-313.
67. Babayan VK: Medium chain triglycerides and structured lipids. Lipids 1987, 22:417-420.
68. Bach AC, Ingenbleek Y, Frey A: The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy? J Lipid Res 1996, 37:708-726.
69. St-Onge MP, Jones PJ: Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity J Nutr 2002, 132:329-332.
70. St-Onge MP, Ross R, Parsons WD, et al.: Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res 2003, 11:395-402.
71. St-Onge MP, Jones PJ: Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue. Int J Obes Relat Metab Disord 2003, 27:1565-1571.
72. St-Onge MP, Bourque C, Jones PJ, et al.: Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int J Obes Relat Metab Disord 2003, 27 95-102.
73. St-Onge MP, Lamarche B, Manger JE et al.: Consumption of a functional oil rich in phytosterols and medium-chain triglyceride oil improves plasma lipid profiles in men. J Nutr 2003, 133:1815-1820.
74. Forbes Medi-Tech, Inc.: Vivola ™ oil. http://www.forbesmedi.com/s/VivolaOil.asp. Accessed August 11, 2004.
75. Taguchi H, Watanabe H, Onizawa K, et al.: Double-blind controlled study on the effects of dietary diacylglycerol on postprandial serum and chylomicron triacylglycerol responses in healthy humans. J Am Coll Nutr 2000, 19:789-796.
76. Tada N, Watanabe H, Matsuo N, et al.: Dynamics of postprandial remnant-like lipoprotein particles (RLP) in serum after loading of diacylglycerols. Clin Chem Acta 2001, 311 109-117.
77. Yamamoto K, Asakawa H, Tokunaga K, et al.: Long-term ingestion of dietary diacylglycerol lowers serum triacylglycerol in Type II diabetic patients with hypertriglyceridemia. J Nutr 2001, 131:3204-3207.
78. Nagao T, Watanabe H, Goto N, et al.: Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double-blind controlled trial. J Nutr 2000, 130:792-797.
79. Maki KC, Davidson MH, Tsushima R, et al.: Consumption of diacylglycerol oil as part of a reduced-energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil. Am J Clin Nutr 2002, 76 1230-1236.
80. Kamphuis MM, Mela DJ, Westerterp-Plantenga MS: Diacylglycerols affect substrate oxidation and appetite in humans. Am J Clin Nutr 2003, 77:1133-1139.
81. Megurc, S, Higashi K, Hase T, et al.: Solubilisation of phytosterols in diacylglycerols versus triacylglycerol improves the serum cholesterol-lowering effect. Eur J Clin Nutr 2001, 55 513-517.
82. Enzymotech: Products: MultiOil Food. http://www.enzymotec.com/page.asp?div=Products&group=5. Accessed August 11, 2004.